PMVP CIK: 1699382

PMV Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
301
FY22:
247
FY23:
207
FY24:
176
FY25:
115
(positive)
Change from FY21 to FY25
millions USD
FY21:
30.3
FY22:
23.3
FY23:
44.7
FY24:
15.6
FY25:
1.34
Total assets
Change from FY21 to FY25
millions USD
FY21:
332
FY22:
270
FY23:
252
FY24:
191
FY25:
117

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
12.2
FY22:
10.8
FY23:
14.0
FY24:
14.4
FY25:
11.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
10.8
FY22:
13.4
FY23:
12.4
FY24:
0.84
FY25:
0.44
(positive)
Change from FY21 to FY25
millions USD
FY21:
309
FY22:
246
FY23:
226
FY24:
176
FY25:
105
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
332
FY22:
270
FY23:
252
FY24:
191
FY25:
117

All amounts in millions USD Data source:SEC EDGAR